What if recombinant DNA or biohazardous reagents are involved?
Projects involving the use of recombinant DNA molecules, human materials, or biohazardous reagents require prior approval by the Institutional Biosafety Committee (IBC). An IBC application for the registration of such projects should be completed, signed and sent to the Office of Research Services for forwarding to the IBC for review. These requirements apply to both funded and non-funded research. The guidelines and application are available from the IBC home page.